BioCen Natural Products Development Group Announces Health Product Breakthrough in Algae Derived Nutritional Drink Product
14 October 2010 - 12:11AM
BioCen Natural Products Development Group (Pink
Sheets:BNPD)
(Formerly Bionic Products, Inc.)
President Daniel J. Kennedy today commented, "We are pleased to
announce that the development of BNPD's first commercial health
drink, Vitamin 'X', is near completion." For the past 8 weeks, BNPD
has been performing test market analysis to determine the best
flavor(s) and percentage of Astaxanthin actives for each bottle.
The Company is also developing a 1-fluid ounce concentrated
Vitamin "X" shot that will provide a quick alternative to a full
beverage product. Each product will contain equal amounts of the
beneficial Astaxanthin.
BNPD is continuing to support the efforts of BioCentric Energy
Holdings, Inc. (Pink Sheets:BEHL) in cultivation and scale up of
Haematococcus for its first commercial site located in Death Valley
Junction, California. For the past 3 weeks, the lab staff has
traveled to Death Valley Junction to test the Haematococcus that
has been strategically placed in test containers on site. The team
is very pleased with the growth rate of the Haematococcus and how
well this strain is thriving in the harsh DVJ environment.
The BNPD lab department, in conjunction with marketing team, is
working together on furthering their research on the incredible
health benefits of Astaxanthin. Such benefits include; reduced risk
of cancer, reduction of inflammation, UV protection and muscle
recovery, just to name a few.
BNPD is receiving inquires from shareholders wanting know when
the inoculation of Haematococcus and harvesting of the Astaxanthin
will take place. BNPD's CEO, Ms. Monique Berry, stated today that,
"We are making great strides and working day and night preparing
and planning for inoculation. We have lab staff working at our
headquarters in Santa Ana, California 7 days a week and traveling
each week to Death Valley Junction just to monitor the growth of
this valuable strain. We will announce the anticipated date of our
first inoculation by the end of October." BNPD's
Marketing Director, Marla Kennedy and Product Development Manager,
Renate Gass are finalizing the packaging and marketing materials
for BNPD products to be sold this year.
The BioCen Natural Products Development Group logo is available
at http://www.globenewswire.com/newsroom/prs/?pkgid=7886
Safe Harbor Statement: This release includes forward-looking
statements intended to qualify for the safe harbor from liability
established by the Private Securities Litigation Reform Act of
1995. These forward-looking statements generally can be identified
by phrases such as BNPD or its management "believes," "expects,"
"anticipates," "foresees," "forecasts," "estimates" or other words
or phrases of similar import. Similarly, statements herein that
describe the Company's business strategy, outlook, objectives,
plans, intentions or goals also are forward-looking statements. All
such forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statements.
CONTACT: BioCen Natural Products Development Group, Inc.
Daniel J. Kennedy, President
714-966-1234
www.bnpdgroup.com
BioCentric Energy
Monique Berry, President
714-966-1234
www.biocentricenergy.com
Biocentric Energy (CE) (USOTC:BEHL)
Historical Stock Chart
From Nov 2024 to Dec 2024
Biocentric Energy (CE) (USOTC:BEHL)
Historical Stock Chart
From Dec 2023 to Dec 2024